Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04181463 · ClinicalTrials.gov registry record · Phase 2
Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- Phase 2
- Development phase
- 112
- Enrollment target
NCT04181463: Clinical Trial Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT04181463 is a Phase 2 study that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04181463, a Phase 2 study, has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 112 participants
- Enrollment target
Study Summary
The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.
Interventions
- OTHER Placebo
- OTHER Questionnaire Administration
- DRUG Isopropyl Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2026-11-05 |
| Est. Completion | 2028-12-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04181463
The ClinicalTrials.gov registry entry for NCT04181463 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04181463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04181463 about?
NCT04181463 is a clinical study titled "Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer". The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.
What is the current status of trial NCT04181463?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 112 participants. The study started on 2026-11-05. Estimated completion is 2028-12-30.
What interventions are being tested in trial NCT04181463?
The interventions under investigation include: Placebo (OTHER), Questionnaire Administration (OTHER), Isopropyl Alcohol (DRUG).
Who is sponsoring clinical trial NCT04181463?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.